NeuroBo Pharmaceuticals (NRBO) Competitors $0.72 0.00 (0.00%) As of 07/11/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock NRBO vs. ARBK, JFU, GLBZ, ANY, NCPL, SAIH, LMFA, MCVT, SLNH, and MIGIShould you be buying NeuroBo Pharmaceuticals stock or one of its competitors? The main competitors of NeuroBo Pharmaceuticals include Argo Blockchain (ARBK), 9F (JFU), Glen Burnie Bancorp (GLBZ), Sphere 3D (ANY), Netcapital (NCPL), SAIHEAT (SAIH), LM Funding America (LMFA), Mill City Ventures III (MCVT), Soluna (SLNH), and Mawson Infrastructure Group (MIGI). These companies are all part of the "banking" industry. NeuroBo Pharmaceuticals vs. Its Competitors Argo Blockchain 9F Glen Burnie Bancorp Sphere 3D Netcapital SAIHEAT LM Funding America Mill City Ventures III Soluna Mawson Infrastructure Group Argo Blockchain (NASDAQ:ARBK) and NeuroBo Pharmaceuticals (NASDAQ:NRBO) are both small-cap banking companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, valuation, earnings, dividends, institutional ownership, risk, media sentiment and analyst recommendations. Do institutionals & insiders believe in ARBK or NRBO? 2.4% of Argo Blockchain shares are held by institutional investors. Comparatively, 1.4% of NeuroBo Pharmaceuticals shares are held by institutional investors. 1.1% of NeuroBo Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media favor ARBK or NRBO? In the previous week, Argo Blockchain had 3 more articles in the media than NeuroBo Pharmaceuticals. MarketBeat recorded 3 mentions for Argo Blockchain and 0 mentions for NeuroBo Pharmaceuticals. Argo Blockchain's average media sentiment score of 0.88 beat NeuroBo Pharmaceuticals' score of 0.00 indicating that Argo Blockchain is being referred to more favorably in the media. Company Overall Sentiment Argo Blockchain Positive NeuroBo Pharmaceuticals Neutral Do analysts recommend ARBK or NRBO? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Argo Blockchain 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50NeuroBo Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is ARBK or NRBO more profitable? NeuroBo Pharmaceuticals has a net margin of 0.00% compared to Argo Blockchain's net margin of -117.38%. Argo Blockchain's return on equity of 0.00% beat NeuroBo Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Argo Blockchain-117.38% N/A -79.90% NeuroBo Pharmaceuticals N/A -189.12%-122.31% Which has better valuation & earnings, ARBK or NRBO? NeuroBo Pharmaceuticals has lower revenue, but higher earnings than Argo Blockchain. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioArgo Blockchain$47.02M0.46-$55.10M-$0.97-0.31NeuroBo PharmaceuticalsN/AN/A-$12.47MN/AN/A Which has more risk and volatility, ARBK or NRBO? Argo Blockchain has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500. Comparatively, NeuroBo Pharmaceuticals has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500. SummaryArgo Blockchain beats NeuroBo Pharmaceuticals on 8 of the 11 factors compared between the two stocks. Get NeuroBo Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRBO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRBO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRBO vs. The Competition Export to ExcelMetricNeuroBo PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.19M$872.67M$5.62B$9.09BDividend YieldN/A4.84%5.24%4.00%P/E RatioN/A1.3828.1320.27Price / SalesN/A239.36428.2698.57Price / CashN/A17.6937.4658.16Price / Book0.486.588.045.49Net Income-$12.47M-$23.83M$3.18B$250.45M7 Day Performance10.82%1.59%3.62%4.79%1 Month Performance-7.35%12.08%4.06%7.68%1 Year Performance-85.64%4.39%30.01%16.43% NeuroBo Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRBONeuroBo PharmaceuticalsN/A$0.72flatN/A-85.2%$6.19MN/A0.0010Gap DownARBKArgo Blockchain0.9646 of 5 stars$0.29+11.7%N/A-72.7%$21.22M$48.52M-0.3040News CoverageGap UpHigh Trading VolumeJFU9F1.8425 of 5 stars$1.67+15.6%N/A-22.7%$19.56M$58.09M0.00740News CoveragePositive NewsGLBZGlen Burnie Bancorp1.8835 of 5 stars$5.67-0.6%N/A+37.9%$16.46M$16.37M568.0780Positive NewsANYSphere 3D3.0646 of 5 stars$0.60+1.5%$3.00+396.7%-31.4%$15.96M$16.61M-1.0620Positive NewsGap UpNCPLNetcapital0.3326 of 5 stars$6.56-6.3%N/A+4.9%$14.41M$4.95M-0.33N/AGap UpSAIHSAIHEATN/A$8.05+2.3%N/AN/A$14.09M$5.54M0.0037Gap UpLMFALM Funding America1.3419 of 5 stars$2.43+3.4%N/A-40.9%$12.45M$11M-0.368News CoverageAnalyst DowngradeGap UpMCVTMill City Ventures III3.1671 of 5 stars$1.85-2.1%N/A-33.9%$11.22M$3.30M9.742SLNHSoluna1.8663 of 5 stars$0.81+18.7%N/A-71.5%$11.12M$31.41M-0.0760High Trading VolumeMIGIMawson Infrastructure Group1.2825 of 5 stars$0.50flatN/A-57.0%$9.80M$59.26M-0.3440Positive NewsGap Up Related Companies and Tools Related Companies Argo Blockchain Alternatives 9F Alternatives Glen Burnie Bancorp Alternatives Sphere 3D Alternatives Netcapital Alternatives SAIHEAT Alternatives LM Funding America Alternatives Mill City Ventures III Alternatives Soluna Alternatives Mawson Infrastructure Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRBO) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroBo Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroBo Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.